While GLP-1 drugs are already known to reduce appetite and slow digestion, the study introduces RES-010, which goes further: it reprograms fat metabolism so the body relies more on stored fat for energy, increases mitochondrial activity, and helps convert white fat to brown fat
If youre considering whether prescription GLP-1 treatment is the right next step, you can complete the free assessment quiz before getting started
2009), while DURATION-6 showed substantial decreases in both HbA1c and weight with liraglutide relative to weekly exenatide (Drucker et al
This approach allows assessment of individual response and minimizes the impact of any unexpected sensitivity
[4] Understanding how these medications work helps patients and clinicians make informed decisions about their use, especially when managing multiple conditions such as diabetes and high blood pressure
Until the results of these studies are available, CVOTs and CREDENCE account for the current dataset related to renal protection across a large cohort of patients with a range of baseline kidney and CV disease related to T2D